KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Other Non-Current Liabilities (2018 - 2021)

Historic Other Non-Current Liabilities for Progyny (PGNY) over the last 4 years, with Q3 2021 value amounting to $438000.0.

  • Progyny's Other Non-Current Liabilities fell 2901.13% to $438000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $438000.0, marking a year-over-year decrease of 2901.13%. This contributed to the annual value of $876000.0 for FY2020, which is N/A changed from last year.
  • Per Progyny's latest filing, its Other Non-Current Liabilities stood at $438000.0 for Q3 2021, which was down 2901.13% from $876000.0 recorded in Q2 2021.
  • In the past 5 years, Progyny's Other Non-Current Liabilities registered a high of $17.0 million during Q3 2019, and its lowest value of $327000.0 during Q2 2020.
  • Over the past 4 years, Progyny's median Other Non-Current Liabilities value was $876000.0 (recorded in 2020), while the average stood at $3.2 million.
  • Per our database at Business Quant, Progyny's Other Non-Current Liabilities tumbled by 9637.23% in 2020 and then soared by 16788.99% in 2021.
  • Quarter analysis of 4 years shows Progyny's Other Non-Current Liabilities stood at $4.6 million in 2018, then soared by 270.63% to $17.0 million in 2019, then plummeted by 94.85% to $876000.0 in 2020, then tumbled by 50.0% to $438000.0 in 2021.
  • Its Other Non-Current Liabilities was $438000.0 in Q3 2021, compared to $876000.0 in Q2 2021 and $876000.0 in Q1 2021.